Micro-RNAs and Next Generation Sequencing: New perspectives in Heart Failure

Clinica Chimica Acta

Volumn 443, Issue , 2015, Pages 114-119

  Chini, Vasiliki P ^a  

^a HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

Author keywords

Heart Failure; MiRNA; Next Generation Sequencing

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 107; MICRORNA 122; MICRORNA 125B; MICRORNA 126; MICRORNA 139; MICRORNA 142; MICRORNA 22; MICRORNA 29B; MICRORNA 320; MICRORNA 423; MICRORNA 497; MICRORNA 92B; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; DATA ANALYSIS; DIAGNOSTIC VALUE; DRUG TARGETING; HEART FAILURE; HUMAN; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; BIOLOGY; GENETICS;

BIOMARKERS; COMPUTATIONAL BIOLOGY; HEART FAILURE; HUMANS; MICRORNAS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 84924277164     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.11.020     Document Type: Article

References (42)

1. Quiat D., Olson E.N. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest 2013, 123(1):11-18.
2. Ikeda S., Pu W.T. Expression and Function of microRNAs in heart disease. Curr Drug Targets 2010, 11(7):1-13.
3. Divakaran V., Mann D.L. The emerging role of MicroRNAs in cardiac remodeling and heart failure. Circ Res 2008, 103:1072-1083.
4. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007, 100:416-424.
5. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006, 103:18255-18260.
6. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618.
7. Tatsuguchi M., Seok H.Y., Callis T.E., Thomson J.M., Chen J.F., Newman M., et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007, 42:1137-1141.
8. Gurha P., Wang T., Larimore A.H., Sassi Y., Abreu-Goodger C., Maricela Ramirez M.O., et al. MicroRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription. PLoS One 2013, 8(9):e75882.
9. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009, 119:2772-2786.
10. Montgomery R.L., Hullinger T.G., Semus H.M., Dickinson B.A., Seto A.G., Lynch J.M., et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 2011, 124:1537-1547.
11. Puckelwartz M.J., McNally E.M. Genetic profiling for risk reduction in human cardiovascular disease. Genes 2014, 5:214-234.
12. Zhao Y., Ransom J.F., Li A., Vedantham V., von Drehle M., Muth A.N., et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007, 129:303-317.
13. Zampetaki A., Willeit P., Drozdov I., Kiechl S., Mayr M. Profiling of circulating micro-RNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012, 93:555-562.
14. Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010, 56:1733-1741.
15. Van Empel V.P.M., De Windt L.J., da Costa Martins P.A. Circulating miRNAs: reflecting or affecting cardiovascular disease?. Curr Hypertens Rep 2012, 14(6):498-509.
16. Markham D.W., Hill J.A. MicroRNAs and heart failure diagnosis miR-acle or miR-age?. Circ Res 2010, 106:1011-1013.
17. Goren Y., Kushnir M., Zafrir B., Tabak S., Lewis B.S., Amir O. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 2012, 14(2):147-154.
18. Mendes N.D., Freitas A.T., Sagot M.F. Current tools for the identification of miRNA genes and their targets. Nucleic Acids Res 2009, 37:2419-2433.
19. Da Costa Martins P.A., De Windt L.J. MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 2012, 93:563-572.
20. Tijsen A.J., Pinto Y.M., Creemers E.E. Non-cardiomyocyte microRNAs in heart failure. Cardiovasc Res 2012, 93:573-582.
21. Han M., Yang Z., Sayed D., He M., Gao S., Lin L., et al. GATA4 expression is primarily regulated via an miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. Cardiovasc Res 2012, 93:645-654.
22. Shantikumar S., Caporali A., Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 2012, 93:583-593.
23. Caroli A., Cardillo M.T., Galea R., Biasucci L.M. Potential therapeutic role of microRNAs in ischemic heart disease. J Cardiol 2013, 61(5):315-320.
24. McDonald R.A., Hata A., MacLean M., Morrell N.W., Baker A.H. MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovasc Res 2012, 93:594-604.
25. Kent O.A., Mendell J.T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006, 25(46):6188-6196.
26. Jakob P., Landmesser U. Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc Res 2012, 93:614-622.
27. Pfaff N., Fiedler J., Holzmann A., Schambach A., Moritz T., Cantz T., et al. miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2. EMBO Rep 2011, 12:1153-1159.
28. Lu C., Tej S.S., Luo S., Haudenschild C.D., Meyers B.C., Green P.J. Elucidation of the small RNA component of the transcriptome. Science 2005, 309(5740):1567-1569.
29. Ruby J.G., Jan C., Player C., Axtell M.J., Lee W., Nusbaum C., et al. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 2006, 127(6):1193-1207.
30. Witten D., Tibshirani R., Gu S.G., Fire A., Lui W.O. Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 2010, 8(1):58.
31. Wu Q., Lu Z., Li H., Lu J., Guo L., Ge Q. Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol 2011, 2011:597145.
32. Lee L.W., Zhang S., Etheridge A., Ma L., Martin D., Galas D., et al. Complexity of the microRNA repertoire revealed by next-generation sequencing. RNA 2010, 16:2170-2180.
33. Leptidis S., el Azzouzi H., Lok S.I., de Weger R., Olieslagers S., Kisters N., et al. A deep sequencing approach to uncover the miRNOME in the human heart. PLoS One 2012, 8(2):e57800.
34. Sana J., Faltejskova P., Svoboda M., et al. Novel classes of non-coding RNAs and cancer. J Transl Med 2012, 10:103.
35. Moldovan L., Batte K.E., Trgovcich J., Wisler J., Marsh C.B., Melissa Piper Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 2014, 18(3):371-390.
36. Creemers E.E., Tijsen A.J., Pinto Y.M. Circulating microRNAs novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res 2012, 110:481-482.
37. Humphreys D.T., Hynes C.J., Patel H.R., Wei G.H., Cannon L., Fatkin D., et al. Complexity of murine cardiomyocyte miRNA biogenesis, sequence variant expression and function. PLoS One 2012, 7:e30933.
38. Hynes C.J., Clancy J.L., Preiss T. miRNAs in cardiac disease: sitting duck or moving target?. Life 2012, 64(11):872-878.
39. Corder K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
40. Mayorga M.E., Penn M.S. miR-145 is differentially regulated by TGF-beta1 and ischaemia and targets Disabled-2 expression and wnt/beta-catenin activity. J Cell Mol Med 2012, 16:1106-1113.
41. Caruso P., Dempsie Y., Stevens H.C., McDonald R.A., Long L., Lu R., et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patients samples. Circ Res 2012, 111(3):290-300.
42. Xu F., Wang Q., Zhang F., Zhu Y., Gu Q., Wu L., et al. Impact of next-generation sequencing (NGS) technology on cardiovascular disease research. Cardiovasc Diagn Ther 2012, 2(2):138-146.